Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction.

Min HS, Kim JE, Lee MH, Song HK, Kang YS, Lee MJ, Lee JE, Kim HW, Cha JJ, Chung YY, Hyun YY, Han JY, Cha DR.

Lab Invest. 2014 Jun;94(6):598-607. doi: 10.1038/labinvest.2014.50.

2.

Wen-pi-tang-Hab-Wu-ling-san reduces ureteral obstructive renal fibrosis by the reduction of oxidative stress, inflammation, and TGF-beta/Smad2/3 signaling.

Jung KJ, Kim J, Park YK, Yoon YR, Park KM.

Food Chem Toxicol. 2010 Feb;48(2):522-9. doi: 10.1016/j.fct.2009.11.006.

PMID:
19913069
3.

Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice.

Sugiyama H, Kobayashi M, Wang DH, Sunami R, Maeshima Y, Yamasaki Y, Masuoka N, Kira S, Makino H.

Nephrol Dial Transplant. 2005 Dec;20(12):2670-80.

4.

DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury.

Eun Lee J, Kim JE, Lee MH, Song HK, Ghee JY, Kang YS, Min HS, Kim HW, Cha JJ, Han JY, Han SY, Cha DR.

Lab Invest. 2016 May;96(5):547-60. doi: 10.1038/labinvest.2016.34.

PMID:
26878135
5.

Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy.

Omori H, Kawada N, Inoue K, Ueda Y, Yamamoto R, Matsui I, Kaimori J, Takabatake Y, Moriyama T, Isaka Y, Rakugi H.

Clin Exp Nephrol. 2012 Aug;16(4):549-56. doi: 10.1007/s10157-012-0609-3.

PMID:
22350467
6.

Role of cyclooxygenase-2 in the development of interstitial fibrosis in kidneys following unilateral ureteral obstruction in mice.

Kamata M, Hosono K, Fujita T, Kamata K, Majima M.

Biomed Pharmacother. 2015 Mar;70:174-80. doi: 10.1016/j.biopha.2015.01.010.

PMID:
25776498
7.

Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction.

Skuginna V, Lech M, Allam R, Ryu M, Clauss S, Susanti HE, Römmele C, Garlanda C, Mantovani A, Anders HJ.

PLoS One. 2011 Apr 22;6(4):e19204. doi: 10.1371/journal.pone.0019204.

8.

Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.

Guo G, Morrissey J, McCracken R, Tolley T, Klahr S.

Am J Physiol. 1999 Nov;277(5 Pt 2):F766-72.

9.

Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.

Vieira JM Jr, Mantovani E, Rodrigues LT, Dellê H, Noronha IL, Fujihara CK, Zatz R.

Nephrol Dial Transplant. 2005 Aug;20(8):1582-91.

10.

C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice.

Li ZI, Chung AC, Zhou L, Huang XR, Liu F, Fu P, Fan JM, Szalai AJ, Lan HY.

Lab Invest. 2011 Jun;91(6):837-51. doi: 10.1038/labinvest.2011.42.

11.

Tempol attenuates renal fibrosis in mice with unilateral ureteral obstruction: the role of PI3K-Akt-FoxO3a signaling.

Yoon HE, Kim SJ, Kim SJ, Chung S, Shin SJ.

J Korean Med Sci. 2014 Feb;29(2):230-7. doi: 10.3346/jkms.2014.29.2.230.

12.
13.

NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury.

Nlandu Khodo S, Dizin E, Sossauer G, Szanto I, Martin PY, Feraille E, Krause KH, de Seigneux S.

J Am Soc Nephrol. 2012 Dec;23(12):1967-76. doi: 10.1681/ASN.2012040373.

14.

Sustained-release prostacyclin analog ONO-1301 ameliorates tubulointerstitial alterations in a mouse obstructive nephropathy model.

Nasu T, Kinomura M, Tanabe K, Yamasaki H, Htay SL, Saito D, Hinamoto N, Watatani H, Ujike H, Suzuki Y, Sugaya T, Sugiyama H, Sakai Y, Matsumoto K, Maeshima Y, Makino H.

Am J Physiol Renal Physiol. 2012 Jun 15;302(12):F1616-29. doi: 10.1152/ajprenal.00538.2011.

15.

Sulfasalazine reduces inflammatory renal injury in unilateral ureteral obstruction.

Demirbilek S, Emre MH, Aydin EN, Edali MN, Aksoy RT, Akin M, Gürünlüoğlu K, Tas E, Ay S, Yilmaz Z.

Pediatr Nephrol. 2007 Jun;22(6):804-12.

PMID:
17294223
16.

Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2.

Kim S, Kim SJ, Yoon HE, Chung S, Choi BS, Park CW, Shin SJ.

Int J Med Sci. 2015 Oct 21;12(11):891-904. doi: 10.7150/ijms.13187.

17.

Nitric oxide in obstructive uropathy: role of endothelial nitric oxide synthase.

Chang B, Mathew R, Palmer LS, Valderrama E, Trachtman H.

J Urol. 2002 Oct;168(4 Pt 2):1801-4.

PMID:
12352363
18.

Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.

Kodera R, Shikata K, Takatsuka T, Oda K, Miyamoto S, Kajitani N, Hirota D, Ono T, Usui HK, Makino H.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):828-33. doi: 10.1016/j.bbrc.2013.12.049.

PMID:
24342619
19.

Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers.

Lim KS, Cho JY, Kim BH, Kim JR, Kim HS, Kim DK, Kim SH, Yim HJ, Lee SH, Shin SG, Jang IJ, Yu KS.

Br J Clin Pharmacol. 2009 Dec;68(6):883-90. doi: 10.1111/j.1365-2125.2009.03376.x.

20.

[Effects of reduced glutathione on contents of hydroxyproline and oxidation stress reaction in kidney of unilateral ureteral obstruction in rat].

Na Y, Zhang XX, Zhang XD, Yuan HP, Hu XL, Zheng W, Li G.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Dec;19(12):735-8. Chinese.

Items per page

Supplemental Content

Support Center